Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Mar 30
 +3.72 / +3.57%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 125.50, with a high estimate of 160.00 and a low estimate of 91.00. The median estimate represents a +16.44% increase from the last price of 107.78.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -133.93%
Growthannually 38.62%


Growthquarterly -36.35%
Growthannually 8.58%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account